MAP2K1 and neoplasm: Moreover, previous studies found that knocking out MEK1 in tumour cells can induce immunogenic antigen presentation genes (Dennison et al., 2021) and MEK1 inhibitors can promote immune responses (Baumann et al., 2020; Prasad et al., 2022).